At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BEAT Heartbeam Inc
Pre-Mkt 11-04 09:21:20 EST
0.4301
+0.0211
+5.16%
盘前0.4508
+0.0207+4.81%
09:17 EST
High0.4755Low0.4170Vol1.00M
Open0.4270D1 Closing0.4090Amplitude14.30%
Mkt Cap24.24MTradable Cap18.80MTotal Shares56.35M
T/O438.75KT/O Rate2.30%Tradable Shares43.71M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Press Release: HeartBeam to Host Third Quarter 2026 Results Conference Call on Thursday, November 12, 2026 at 4:30 P.m. Eastern Time
Dow Jones  ·  11-03 21:31
Press Release: HeartBeam to Host Third Quarter 2026 Results Conference Call on Thursday, November 12, 2026 at 4:30 P.m. Eastern Time
HeartBeam announces results from ALIGN-ACS pilot study of HeartBeam System
TIPRANKS  ·  11-02 21:41
HeartBeam announces results from ALIGN-ACS pilot study of HeartBeam System
HeartBeam Device Shows Higher Specificity than Standard ECG in Heart Attack Pilot Study
Reuters  ·  11-02 21:32
HeartBeam Device Shows Higher Specificity than Standard ECG in Heart Attack Pilot Study
HeartBeam Plans ALIGN-ACS Heart Attack Assessment Study Results Presentation at TCT
Reuters  ·  10-28
HeartBeam Plans ALIGN-ACS Heart Attack Assessment Study Results Presentation at TCT
HeartBeam announces U.S. FDA accepted HeartBeat System to its TAP Pilot
TIPRANKS  ·  10-26
HeartBeam announces U.S. FDA accepted HeartBeat System to its TAP Pilot
Heartbeam - FDA Accepts Heartbeam System into Total Product Life Cycle Advisory Program (Tap) Pilot
THOMSON REUTERS  ·  10-26
Heartbeam - FDA Accepts Heartbeam System into Total Product Life Cycle Advisory Program (Tap) Pilot
Heartbeam - Expects to Begin Patient Enrollment for Multicenter Pivotal Study in Q1 2027
THOMSON REUTERS  ·  10-26
Heartbeam - Expects to Begin Patient Enrollment for Multicenter Pivotal Study in Q1 2027
HeartBeam announces HEADSTART-ACS study completed enrollment
TIPRANKS  ·  10-21
HeartBeam announces HEADSTART-ACS study completed enrollment
HeartBeam Completes Enrollment Ahead of Schedule in 486-Patient Heart Attack Detection Study
Reuters  ·  10-21
HeartBeam Completes Enrollment Ahead of Schedule in 486-Patient Heart Attack Detection Study
HeartBeam joins European EXIT-CVD Research Consortium
TIPRANKS  ·  10-15
HeartBeam joins European EXIT-CVD Research Consortium
HeartBeam Joins European EXIT-CVD Consortium to Study At-Home ECG Monitoring
Reuters  ·  10-15
HeartBeam Joins European EXIT-CVD Consortium to Study At-Home ECG Monitoring
Heartbeam Joins European Exit-CVD Research Consortium to Advance At-Home Ecg Monitoring for Early Detection of Acute Coronary Syndrome (Acs) in High-Risk Patients
THOMSON REUTERS  ·  10-15
Heartbeam Joins European Exit-CVD Research Consortium to Advance At-Home Ecg Monitoring for Early Detection of Acute Coronary Syndrome (Acs) in High-Risk Patients
Why These 3 Penny Stocks Are on Investors’ Radar Today
TIPRANKS  ·  10-06
Why These 3 Penny Stocks Are on Investors’ Radar Today
Why Is Penny Stock HeartBeam (BEAT) Up Nearly 60% Today?
TIPRANKS  ·  10-06
Why Is Penny Stock HeartBeam (BEAT) Up Nearly 60% Today?
HeartBeam Wins FDA Breakthrough Device Status for At-Home Heart Attack Assessment System
Reuters  ·  10-05
HeartBeam Wins FDA Breakthrough Device Status for At-Home Heart Attack Assessment System
Heartbeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
THOMSON REUTERS  ·  10-05
Heartbeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
Beat Reports Valuation Loss on Bitcoin ETF Holding as of September
MT Newswires Live  ·  10-05
Beat Reports Valuation Loss on Bitcoin ETF Holding as of September
Heartbeam Cut to Neutral from Buy by HC Wainwright & Co.
Dow Jones  ·  09-23
Heartbeam Cut to Neutral from Buy by HC Wainwright & Co.
Heartbeam, Inc. : H.c. Wainwright Cuts to Neutral from Buy
THOMSON REUTERS  ·  09-22
Heartbeam, Inc. : H.c. Wainwright Cuts to Neutral from Buy
US Research Roundup-Boeing, Twilio, WP Carey
Reuters  ·  09-22
US Research Roundup-Boeing, Twilio, WP Carey

Introduction

Company Name.
Heartbeam Inc
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
Issue price:
--